Dossier
PreCheck program
Coverage of PreCheck program in the Nexus archive.
- FDA picks Eli Lilly and Regeneron for program to speed up domestic drug factory reviews
The FDA has selected Eli Lilly and Regeneron for its PreCheck program, which aims to expedite domestic drug factory reviews by assessing facilities during construction. The program could save participating companies up to 14 months in review time.